# Pyxis Oncology, Inc.: Form DEF 14A, filed Sep 25, 2024

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: DEF 14A
- Filed: 2024-09-25
- Accepted by EDGAR: Sep 25, 2024, 20:08 ET
- Period: 2024-09-25
- Accession: 0000950170-24-109337
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000095017024109337/2024_pyxs-special_mtg_14.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000095017024109337/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000095017024109337/2024_pyxs-special_mtg_14.htm

Filed Sep 25, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-109337. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.